Morningstar® Stock Report™

Johnson & Johnson JNJ

Gewinnmarge (% des Umsatzes)
20192020202120222023
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten33,58%34,42%31,84%32,74%31,18%
Bruttogewinn66,42%65,58%68,16%67,26%68,82%
Vertriebsgemeinkosten27,03%26,74%26,30%26,08%23,62%
Forschung und Entwicklung13,84%14,72%15,69%16,21%17,71%
Umsatzrendite25,55%24,11%26,18%24,97%27,49%
Net Int, Inc and Other46,67%44,09%50,46%47,85%45,18%
EBIT Marge21,12%19,98%24,29%22,88%17,69%
Ertragskraft
20192020202120222023
Steuersatz2,69%2,16%2,02%3,99%2,04%
Nettomarge18,42%17,82%22,26%18,90%41,28%
Gesamtkapitalrendite9,738,8511,709,7119,81
Financial Leverage2,652,762,462,442,44
Eigenkapitalsrendite25,3623,9730,4123,7948,29